You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Patent: 8,431,532


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,431,532
Title:FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments using same
Abstract: Methods of treatment using Fzd8 extracellular domains (ECDs), Fzd8 ECD fusion molecules, and/or antibodies that bind Fzd8 are provided. Such methods include, but are not limited to, methods of treating obesity and obesity-related conditions. Fzd8 ECDs and Fzd8 ECD fusion molecules are also provided. Polypeptide and polynucleotide sequences, vectors, host cells, and compositions comprising or encoding such molecules are provided. Methods of making and using Fzd8 ECDs, Fzd8 ECD fusion molecules, and antibodies that bind Fzd8 are also provided.
Inventor(s): Brennan; Thomas (San Jose, CA), Lee; Ernestine (Kensington, CA), Smith; Steven (San Francisco, CA)
Assignee: Five Prime Therepeutics, Inc. (South San Francisco, CA)
Application Number:13/169,900
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive Analysis of United States Patent 8,431,532: Claims and Patent Landscape

Introduction

Understanding the intricacies of a patent, particularly one like United States Patent 8,431,532, involves a deep dive into its claims, the patent landscape, and the legal and technical benchmarks that govern its validity. This analysis will cover the key aspects of the patent, including its claims, the criteria for patentability, the examination process, and the broader patent landscape.

Overview of the Patent

United States Patent 8,431,532, hereafter referred to as the '532 patent, is a specific example of a patented invention that has undergone rigorous examination and scrutiny. To analyze this patent, one must first understand the nature of the invention and the claims made within it.

Claims Analysis

Claim Structure and Scope

The claims of a patent define the boundaries of the invention and are crucial for determining what is protected under the patent. For the '532 patent, each claim must be carefully crafted to meet the criteria of novelty, non-obviousness, and usefulness as mandated by U.S. patent law[2].

Novelty and Non-obviousness

For a patent to be granted, the invention must be novel and non-obvious. This means the invention must represent a new idea that has not been previously disclosed and must not be an evident solution to someone skilled in the field. The patent examiners assess this by comparing the invention against prior art, ensuring it differs sufficiently from existing inventions[2].

Abstract Ideas and Practical Application

Algorithms and software inventions, common in modern patents, often face scrutiny under the abstract idea doctrine. For the '532 patent, it is essential that the invention has a practical application in a specific field, transforming an abstract concept into a useful process or machine. This ensures compliance with patent standards and avoids the pitfalls of abstract ideas that are not patentable[2].

Examination Process

Preparing the Patent Application

The process of preparing a patent application involves thorough research on existing patents to ensure the invention is original. Utilizing the USPTO database, detailed documentation of the invention’s functionality and advantages is crucial. This includes clear descriptions of the invention’s novelty, relevant technical diagrams, and an outline of its innovation over existing solutions[2].

Examination by Patent Examiners

After submission, the USPTO assigns the application to a patent examiner who reviews the documentation, searching prior art to verify the novelty of the invention. Initial feedback, often in the form of an "office action," may include rejections or requests for additional information. Engaging promptly with the examiner and addressing their concerns is essential for overcoming objections and achieving patent approval[2][3].

Patent Landscape Analysis

Prior Art and Rejections

Reviewing the file wrappers of the '532 patent can provide valuable insights into the examination process. This includes understanding which prior art was cited against the patent and the arguments made by the examiner. For instance, if claims were rejected under 35 U.S.C. § 102(a)(1) or § 102(a)(2), it would indicate that the examiner found the invention to be anticipated by prior art[3].

Competitive Intelligence

Analyzing the patent landscape involves looking at similar patents and understanding the competitive environment. This can include reviewing the prosecution history of related patents, identifying key players in the field, and understanding the technological advancements and trends. Tools like patent file wrappers and specialized software like LexisNexis PatentOptimizer can streamline this process[3][5].

Legal Precedents and Case Studies

Supreme Court Decisions

The patentability of algorithms and software inventions has been significantly shaped by Supreme Court decisions. Cases like Alice Corp. v. CLS Bank International and Bilski v. Kappos have set strong precedents, emphasizing that abstract ideas implemented through computers or mere mathematical formulas without practical application are not eligible for patents. These decisions are crucial for understanding the patentability of the '532 patent[2].

Federal Circuit Decisions

Decisions from the Federal Circuit, such as those in In re Cellect, provide further guidance on issues like obviousness-type double patenting (ODP) and the impact of Patent Term Adjustments (PTA) on patent validity. These cases highlight the complexities of patent law and the need for careful analysis of each patent’s specific circumstances[1].

Impact on Innovation and Competition

Competitive Advantage

Patenting an invention like the one described in the '532 patent can offer a significant competitive advantage by providing exclusive rights to a novel method or process. This exclusivity can incentivize firms to invest more in research and development, driving innovation forward[2].

Potential Barriers

However, patenting algorithms can also stifle innovation by preventing others from building upon the patented invention. Competitors may face legal barriers, potentially reducing the diversity of technological solutions available in the market. The patenting process itself can be lengthy and expensive, discouraging smaller firms from participating in certain technological advancements[2].

Key Takeaways

  • Claims Must Be Specific: The claims of the '532 patent must be carefully crafted to meet the criteria of novelty, non-obviousness, and usefulness.
  • Practical Application: The invention must have a practical application to avoid being classified as an abstract idea.
  • Examination Process: Engaging with patent examiners and addressing their concerns promptly is crucial for overcoming objections.
  • Legal Precedents: Understanding Supreme Court and Federal Circuit decisions is essential for navigating the patent landscape.
  • Competitive Intelligence: Analyzing the patent landscape and using tools like patent file wrappers can provide valuable insights.

FAQs

Q: What are the key criteria for patenting an algorithm?

A: An algorithm must be novel, non-obvious, and have a practical application in a specific field. It must also meet the eligibility criteria for patentable subject matter[2].

Q: How does the USPTO examine patent applications for algorithms?

A: The USPTO assigns a patent examiner who reviews the documentation, searching prior art to verify the novelty of the algorithm. The examiner may issue office actions, which the applicant must address to overcome objections[2][3].

Q: What is the impact of Supreme Court decisions on algorithm patents?

A: Decisions like Alice Corp. v. CLS Bank International and Bilski v. Kappos have set precedents that abstract ideas implemented through computers or mere mathematical formulas without practical application are not eligible for patents[2].

Q: How can analyzing patent file wrappers help in competitive intelligence?

A: Analyzing patent file wrappers provides insights into the examination process, including which prior art was cited and the arguments made by the examiner. This can help in understanding the competitive environment and identifying key players in the field[3].

Q: What are the potential barriers to innovation posed by patenting algorithms?

A: Patenting algorithms can prevent others from building upon the patented invention, potentially reducing the diversity of technological solutions. The process can also be lengthy and expensive, discouraging smaller firms from participating in certain technological advancements[2].

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1].
  2. Can You Patent an Algorithm? - Patent Lawyer[2].
  3. Patent file wrappers as a tool for competitive intelligence - IP Checkups[3].
  4. What Is the Probability of Receiving a US Patent? - Yale Journal of Law and Technology[4].
  5. PatentOptimizer - LexisNexis Intellectual Property Solutions[5].

More… ↓

⤷  Subscribe

Details for Patent 8,431,532

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Chiesi Farmaceutici S.p.a. MYALEPT metreleptin For Injection 125390 February 24, 2014 8,431,532 2030-06-28
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.